Whistleblowing in Clinical Trials: Is It Worth the Risk?

Send us Fan Mail In this episode, Darshan Kulkarni and Edye Edens explore whether sites should consider whistleblowing on non-compliant sponsors. They acknowledge that non-compliance is a non-negotiable issue, but emphasize the difficulty of deciding when to report, especially given the financial and relational ties between sites and sponsors. They discuss examples, like overpayments or data integrity violations, which might compel a whistleblower to act. However, they highlight the gray area...